multipl
sclerosi
ms
onset
childhood
offer
uniqu
opportun
studi
infecti
background
diseas
immun
reaction
infecti
agent
children
recent
investig
epidemiolog
studi
strongli
implic
involv
one
infecti
agent
aetiolog
ms
epsteinbarr
viru
ebv
prime
candid
rather
actual
caus
ms
probabl
agent
involv
develop
immunoregulatori
pathway
pathway
disturb
hygienerel
factor
includ
alter
sequenc
infect
may
gener
maintain
deficit
within
immunolog
network
facilit
particular
earli
event
develop
ms
preced
onset
ms
diseas
year
decad
framework
serv
guid
epidemiolog
immunolog
molecular
biolog
investig
formul
approach
may
shed
light
complex
natur
histori
ms
may
lead
ration
prevent
therapeut
strategi
possibl
futur
ms
could
prevent
vaccin
ebv
earli
childhood
framework
relev
design
appropri
type
vaccin
pathogenesi
multipl
sclerosi
ms
certainli
complex
heterogen
natur
involv
interplay
innat
environment
factor
genet
factor
notabl
polymorph
hla
epidemiolog
diseas
strongli
indic
emerg
major
neurolog
disord
industri
develop
nation
last
year
like
affect
hygienerel
factor
accord
socal
hygien
hypothesi
modern
live
condit
industrialis
nation
isol
infant
children
mani
infecti
challeng
requir
develop
appropri
immunoregulatori
network
hypothesi
advanc
explain
rise
incid
diseas
associ
immun
dysregul
includ
asthma
allergi
autoimmun
least
form
cancer
industri
develop
world
addit
hypothesi
suggest
strategi
intervent
prevent
diseas
illustr
studi
epidemiolog
malign
melanoma
indic
certain
vaccin
bcg
vaccinia
yellow
fever
substitut
signific
protect
effect
natur
b
krone
infect
epidemiolog
investig
ms
strongli
indic
diseas
likewis
affect
hygienerel
factor
histori
infect
challeng
determin
whether
underli
distort
immun
respons
complex
diseas
could
prevent
correct
therapeut
intervent
evid
epidemiolog
studi
role
mani
common
infect
aetiolog
ms
larg
inconsist
could
due
prolong
silent
stage
diseas
recent
studi
ms
commenc
childhood
might
abl
shed
light
issu
although
convinc
evid
specif
activ
infect
directli
caus
ms
least
specifi
infect
demonstr
associ
diseas
basi
serolog
characterist
epsteinbarr
viru
ebv
emerg
like
singl
candid
lead
aetiolog
role
infect
uniqu
preval
specif
antibodi
consist
higher
children
ms
compar
healthi
agematch
control
wherea
typic
age
onset
ms
late
earli
nearli
patient
control
subject
alreadi
experienc
ebv
infect
two
key
point
emerg
studi
relat
ebv
children
ms
alreadi
infect
ebv
level
antibodi
ebv
antigen
significantli
higher
adult
children
ms
compar
control
context
infect
ebv
usual
occur
infanc
develop
nation
ms
rare
industrialis
nation
infect
usual
occur
later
life
often
delay
adolesc
earli
adulthood
time
diagnosi
ms
children
earlier
ebv
infect
becom
latent
serolog
sign
reactiv
igm
antiearli
antigen
titr
measur
indirect
immuno
fluoresc
assay
moreov
adult
patient
msassoci
serolog
ebv
pattern
probabl
establish
mani
year
onset
clinic
evid
ms
prior
infecti
mononucleosi
strong
risk
factor
ms
manifest
year
mean
around
year
later
taken
togeth
studi
strongli
indic
latent
ebv
infect
essenti
predispos
condit
develop
ms
genet
environment
hygienerel
condit
appear
necessari
actual
express
diseas
unifi
condit
might
dysregul
immun
respons
distinct
possibl
infect
synergis
ebv
aetiolog
diseas
time
infect
might
import
context
chlamydia
pneumonia
cp
infect
may
play
special
role
recent
studi
children
ms
cpspecif
igm
antibodi
point
high
frequenc
fresh
recent
reactiv
infect
pathogen
onset
diseas
final
key
point
demonstr
slight
though
statist
signific
elev
level
antibodi
certain
common
infecti
agent
ebv
cp
occur
children
adult
ms
compar
age
match
control
subject
find
howev
impli
direct
caus
relat
infect
ms
could
reflect
gener
dysregul
immun
function
caus
consequ
develop
diseas
inde
like
elev
antibodi
concentr
signific
per
se
develop
ms
reflect
shift
pattern
immun
reactiv
away
protect
toward
enhanc
risk
diseas
nevertheless
studi
msassoci
infecti
agent
could
lead
identif
specif
antigen
determin
involv
gener
mainten
immun
dysregul
hypothesi
relat
ms
biographi
immun
system
basi
avail
epidemiolog
evid
may
postul
ms
depend
infect
ebv
owe
hygienerel
factor
occur
later
usual
life
circumst
ebv
infect
might
encount
pattern
immun
respons
gener
prior
infect
certain
microorgan
paper
suggest
scenario
sequenc
certain
common
infect
result
immun
dysregul
favour
onset
ms
follow
section
hypothesi
elabor
recent
studi
shown
immun
system
contain
complex
network
regulatori
pathway
extent
pathway
genet
determin
grow
evid
critic
determin
natur
time
infect
immun
challeng
individu
experi
earlier
life
could
term
biographi
immun
system
immunoregulatori
pathway
base
popul
lymphocyt
term
regulatori
cell
reg
current
consider
interest
case
infecti
diseas
popul
may
lead
rapid
resolut
establish
latent
persist
infect
tissu
damag
autoimmun
process
accordingli
reg
term
danger
necess
term
impli
reg
neither
good
bad
per
se
may
accord
overal
pattern
respons
particip
appropri
immun
reaction
lead
resolut
diseas
inappropri
one
result
immunopatholog
tempor
sequenc
infect
especi
initi
earli
one
crucial
develop
pattern
immun
reactiv
prior
contact
antigen
may
induc
crossreact
thelper
cell
compet
reg
consequ
reg
normal
induc
second
pathogen
may
margin
even
eclips
latter
phenomenon
also
known
later
inhibit
mani
parallel
biolog
particularli
neurolog
lock
immun
respons
eclips
state
seem
involv
activ
delet
clone
tcell
occur
result
reinfect
reactiv
case
ms
infect
possibl
cp
occur
time
initi
reactiv
ebv
infect
could
effect
thu
prior
contact
could
induc
popul
reg
crucial
role
protect
ms
also
crossreact
epitop
ebv
subsequ
infect
ebv
could
therefor
gener
domin
popul
crossreact
thelpercel
could
suppress
delet
reg
normal
physiolog
condit
reg
could
either
suppress
popul
tcell
would
otherwis
abl
induc
autoimmun
process
includ
involv
pathogenesi
ms
could
caus
expans
popul
specif
tcell
would
immun
repair
function
natur
epitop
epitop
involv
postul
process
remain
unknown
analog
parallel
studi
melanoma
mention
suggest
key
host
epitop
involv
code
certain
human
endogen
retrovirus
herv
activ
extens
document
ms
accordingli
challeng
ms
research
delin
pattern
msrelat
immun
respons
reg
involv
affect
risk
ms
benefici
detriment
like
target
respons
antibodi
concentr
particularli
elev
patient
ms
systemat
studi
thelper
cell
epitop
protein
reveal
tcell
healthi
ebv
carrier
match
msassoci
hladr
allel
recognis
sever
epitop
within
central
region
ctermin
domain
protein
ebvencod
protein
contrast
ms
patient
recognis
mani
epitop
spread
entir
domain
concomitantli
number
memori
tcell
direct
domain
increas
tenfold
ms
shown
thelper
cell
precursor
polaris
effector
memori
cell
contain
subfract
regulatori
tcell
reg
reg
suppress
ms
high
level
tcell
activ
ebv
cytomegaloviru
demonstr
earli
cours
ms
search
possibl
origin
compet
thelper
cell
undertaken
blast
analyt
program
sequenc
homolog
evid
entir
expand
epitop
protein
cp
tabl
possibl
involv
cp
cell
competit
support
observ
target
tand
bcell
found
msassoci
systemat
studi
also
homolog
cp
tabl
central
epitop
margin
ms
amino
acid
feniaeglrallarshv
could
well
differ
function
health
ms
therefor
major
put
candid
gener
reg
control
relev
immun
process
specif
function
defici
reg
ms
recent
recognis
need
larg
cohort
reg
resolut
experiment
autoimmun
encephalomyel
demonstr
purpos
studi
potenti
infecti
immunolog
background
ms
relev
search
homolog
epitop
msassoci
pathogen
interestingli
homolog
put
epitop
found
pathogen
tabl
like
divers
rang
msassoci
infecti
agent
ebv
possibl
cp
involv
gener
maintain
postul
immun
respons
associ
benefici
detriment
ms
gener
popul
reg
compet
thelper
cell
infecti
agent
would
play
role
gener
variou
immunolog
network
base
reg
turn
would
facilit
expans
suppress
popul
effector
cell
includ
epitopespecif
tcell
epitop
recognis
tcell
common
msassoci
infecti
pathogen
one
cellular
gene
product
latter
preferenti
sought
herv
sinc
patient
ms
express
hervw
env
higher
copi
number
compar
control
p
env
genotyp
describ
risk
factor
ms
put
target
epitop
effector
tcell
process
suggest
epitop
identifi
short
peptid
hervw
env
gene
complex
mpvpsapst
predict
peptid
present
though
subdominantli
divers
hla
class
molecul
includ
ld
b
b
determin
refer
syfpeihi
databas
mhc
ligand
peptid
motif
three
pathogen
bear
two
homolog
protein
postul
optim
cooper
correspond
tcell
identifi
name
herp
simplex
viru
tegument
protein
measl
nucleoprotein
varicella
tegument
msassoci
serolog
pathogen
higher
specif
antibodi
concentr
confirm
recent
studi
herp
p
measl
p
varicella
p
epidemiolog
evid
msassoci
major
pathogen
tabl
weak
inconsist
moreov
simultan
occurr
homolog
epitop
also
found
divers
rang
pathogen
caus
respiratori
gastrointestin
infect
also
associ
benefici
specif
tcell
direct
region
found
expand
ms
patient
compar
control
individu
region
homolog
cp
protein
extend
amino
acid
posit
ident
amino
acid
conserv
amino
acid
exchang
miss
amino
acid
arab
number
addit
amino
acid
dkk
pf
detriment
risk
ms
likewis
unknown
parasit
infect
recent
found
associ
reduc
risk
ms
parasit
organ
share
two
homolog
tabl
footnot
addit
preliminari
studi
indic
parasit
infect
ms
patient
lead
fewer
exacerb
link
emerg
reg
rel
widespread
occurr
two
homolog
explain
least
part
infecti
background
ms
prove
complex
difficult
defin
mpvpsapstpeptid
aminotermin
part
small
hypothet
protein
amino
acid
encod
complementari
dna
strand
env
gene
conserv
homolog
hervw
sequenc
human
genom
gene
transcript
open
read
frame
initi
start
codon
found
associ
ms
accord
genet
data
bank
entri
moreov
sever
herv
h
k
l
exhibit
homolog
herv
peptid
selfantigen
could
serv
target
induc
postul
msprotect
immun
respons
main
hla
class
molecul
present
peptid
frequenc
european
popul
shown
associ
significantli
reduc
ms
risk
p
immun
dysregul
ms
like
earli
event
preced
onset
ms
diseas
mani
year
decad
thu
emphas
epidemiolog
observ
possibl
infecti
background
ms
partli
predominantli
reflect
earliest
stage
natur
histori
ms
situat
similar
postul
describ
malign
melanoma
discuss
crossreact
protect
immun
respons
induc
homolog
epitop
bcg
vaccinia
yellow
fever
vaccin
given
least
year
onset
diseas
suggest
melanocyt
earli
stage
malign
transform
may
elimin
repair
tcell
recognis
cell
express
herv
peptid
immun
reaction
seem
suppress
genet
activ
herv
provirus
env
gene
associ
malign
transform
herv
env
protein
probabl
impair
redox
tabl
homolog
protein
seroepidemiolog
msassoci
pathogen
ms
associ
ebvepitop
enhanc
immun
reactiv
ms
patient
comparison
healthi
control
subject
identifi
systemat
studi
consensu
protein
ebv
sequenc
given
ident
amino
acid
similar
amino
acid
conserv
exchang
miss
amino
acid
one
addit
homolog
vaccinia
viru
regul
within
cell
via
reduc
level
glutathion
peroxidas
ms
still
anoth
environment
risk
factor
name
suboptim
level
bioactiv
vitamin
demonstr
rat
astrocyt
may
impair
via
cglutamyl
transpeptidas
intracellular
glutathion
level
tabl
msassoci
pathogen
homolog
protein
thereof
candid
epitop
ebv
put
reg
hervw
ident
amino
acid
conserv
amino
acid
exchang
miss
amino
acid
arab
number
addit
amino
acid
tee
ag
qke
yck
v
v
lat
pathogen
higher
antibodi
concentr
observ
compar
control
individu
homolog
epitop
also
found
follow
pathogen
caus
respiratori
gastrointestin
diseas
bordetella
parapertussi
corynebacterium
diphtheria
cytomegalo
viru
haemophilu
influenza
human
corona
viru
human
rota
viru
mycobacterium
tuberculosi
also
bovi
strain
bcg
salmonella
enterica
pseudomona
aeruginosa
serratia
marcescen
two
parasit
caus
gastrointestin
infect
entamoeba
histolytica
giardia
lamblia
protein
homolog
epitop
respect
adeno
viru
dna
stabil
proteinprotein
v
chlamydia
pneumonia
hypothet
protein
cpb
protein
epsteinbarr
viru
herp
tegumenttegu
herp
tegumenttegu
tegumentmajor
capsid
measl
viru
nucleoproteinnucleoprotein
mycoplasma
pneumonia
phosphat
import
atpbind
protein
pstbenolas
larg
proteinnucleocapsid
rsv
fusion
protein
precursorglycoprotein
rubella
rnadirect
rna
vaccinia
membran
proteinput
dnabind
core
varicella
viru
tegumenttegu
cell
cultur
experi
gangliosid
neolacto
seri
identifi
possibl
relev
mediat
suppress
herv
gene
induc
lytic
replic
cycl
cell
latent
infect
ebv
therebi
releas
viral
antigen
would
readili
recognis
specif
immun
system
failur
protect
mechan
would
facilit
uncontrol
establish
observ
extens
ebv
infect
brain
lymphat
tissu
ms
albeit
low
level
viru
activ
specif
process
brain
may
associ
high
content
gangliosid
nervou
tissu
gangliosid
may
antagon
activ
possibl
protect
ms
multipl
sclerosi
certainli
complex
diseas
entiti
pathogen
process
involv
increas
neurodegener
particular
reduc
remyelin
contribut
diseas
progress
thu
relev
target
addit
herv
peptid
might
exist
possibl
host
protein
homolog
herv
peptid
one
candid
neuronspecif
owe
complementari
bind
site
form
complex
spectrin
anim
model
remyelin
axon
latter
target
immun
repair
mechan
mediat
monoclon
antibodi
base
epidemiolog
consider
postul
rel
high
risk
ms
industrialis
nation
due
hygienerel
chang
sequenc
common
infect
result
emerg
pattern
immun
reactiv
either
caus
fail
protect
develop
ms
epidemiolog
studi
requir
determin
whether
time
ebv
infect
relat
risk
ms
base
studi
alter
immun
respons
certain
infecti
agent
evid
express
herv
ms
epitop
put
role
depend
appropri
inappropri
activ
immunoregulatori
network
protect
predisposit
ms
delin
studi
base
consider
focu
process
initi
ms
year
decad
manifest
diseas
subsequ
better
understand
highli
complex
immunopatholog
ms
hope
lead
eventu
develop
vaccin
strategi
prevent
correct
anomali
immun
function
vaccin
could
well
work
prevent
correct
hygienerel
immun
dysregul
previous
postul
vaccin
base
ebv
afford
high
level
protect
ms
exact
natur
effici
safe
vaccin
would
depend
natur
relationship
ebv
ms
framework
present
studi
principl
confirm
appropri
vaccin
like
live
attenu
one
induc
strong
cell
respons
ebv
epitop
express
ebv
latenc
